Helius Med Technologies Inc.
13F holders, Q2 2025 (June 30)11holders
$0.18avg. 13F price*
At the end of Q2 2025, 11 institutions reported holding Helius Med Technologies Inc. in their 13F filings. The largest holders were Wealthspire Advisors, LLC ($55K), Federation des caisses Desjardins du Quebec ($38K) and UBS Group AG ($7K).
- Company
- Helius Med Technologies Inc.
- CUSIP
- 42328V884
- Latest filing quarter
- Q2 2025
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $106K |
| Exits | 0 | $0 |
Ownership 11 holders
| Wealthspire Advisors, LLC | 0.00% | New | 300,000 | $55K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 200,001 | $38K |
| UBS Group AG | 0.00% | New | 36,829 | $7K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 50,016 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 6,117 | $1K |
| IFP Advisors, Inc | 0.00% | New | 3,333 | $607 |
| Morgan Stanley | 0.00% | New | 123 | $22 |
| JPMorgan Chase & Co. | 0.00% | New | 53 | $10 |
| Bank of America Corp. | 0.00% | New | 4 | $1 |
| American Capital Advisory, LLC | 0.00% | New | 2 | $1 |
| Raymond James Financial Inc. | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is HELIUS MED TECHNOLOGIES INC's weight in each manager's 13F, not the share of Helius Med Technologies Inc. the manager owns.